###begin article-title 0
Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Epithelial to Mesenchymal Transition (EMT) induced by Transforming Growth Factor-beta (TGF-beta) is an important cellular event in organogenesis, cancer, and organ fibrosis. The process to reverse EMT is not well established. Our purpose is to define signaling pathways and transcription factors that maintain the TGF-beta-induced mesenchymal state.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 1148 1153 <span type="species:ncbi:10090">mouse</span>
Inhibitors of five kinases implicated in EMT, TGF-beta Type I receptor kinase (TbetaRI), p38 mitogen-activated protein kinase (p38 MAPK), MAP kinase kinase/extracellular signal-regulated kinase activator kinase (MEK1), c-Jun NH-terminal kinase (JNK), and Rho kinase (ROCK), were evaluated for reversal of the mesenchymal state induced in renal tubular epithelial cells. Single agents did not fully reverse EMT as determined by cellular morphology and gene expression. However, exposure to the TbetaRI inhibitor SB431542, combined with the ROCK inhibitor Y27632, eliminated detectable actin stress fibers and mesenchymal gene expression while restoring epithelial E-cadherin and Kidney-specific cadherin (Ksp-cadherin) expression. A second combination, the TbetaRI inhibitor SB431542 together with the p38 MAPK inhibitor SB203580, was partially effective in reversing EMT. Furthermore, JNK inhibitor SP600125 inhibits the effectiveness of the TbetaRI inhibitor SB431542 to reverse EMT. To explore the molecular basis underlying EMT reversal, we also targeted the transcriptional repressors ZEB1 and ZEB2/SIP1. Decreasing ZEB1 and ZEB2 expression in mouse mammary gland cells with shRNAs was sufficient to up-regulate expression of epithelial proteins such as E-cadherin and to re-establish epithelial features. However, complete restoration of cortical F-actin required incubation with the ROCK inhibitor Y27632 in combination with ZEB1/2 knockdown.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
We demonstrate that reversal of EMT requires re-establishing both epithelial transcription and structural components by sustained and independent signaling through TbetaRI and ROCK. These findings indicate that combination small molecule therapy targeting multiple kinases may be necessary to reverse disease conditions.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo </italic>
###xml 362 363 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 364 365 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 463 464 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 759 760 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 857 862 <span type="species:ncbi:9606">human</span>
Epithelial to Mesenchymal Transition (EMT) is an extreme form of cellular plasticity defined by loss of epithelial cell morphology, dissociation of cell-cell contacts, reduction in proteins mediating cell-cell contacts, remodeling of the actin cytoskeleton, de novo expression of alpha-smooth muscle actin (alpha-SMA), and acquisition of mesenchymal cell shape [1-4]. During EMT, cells diminish epithelial gene expression and acquire mesenchymal gene expression [5]. Cortical actins, the actin filament bundles below the plasma membrane, reorganize or are lost, while stress fibers comprising F-actin are gained. In normal development, EMT has been associated with processes in gastrulation, heart formation, palate formation, and Mullerian tract regression [4]. In disease states, EMT has been exploited in both cancer and organ fibrosis. The mortality in human cancers is caused by primary tumor cells that have undergone oncogenic EMT and metastasized to other organs. Other diseases, such as end-state organ failure by fibrosis, are caused by repeated and sustained infliction of EMT. Thus, understanding the cellular mechanisms to reverse EMT is of great importance.
###end p 8
###begin p 9
###xml 148 149 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 150 151 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 233 234 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 235 236 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 237 238 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 424 425 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 426 427 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 815 817 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1125 1127 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1128 1130 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
The TGF-beta signaling pathway is considered a good target for EMT reversal because it is a key mediator of fibrosis and facilitator of metastasis [3,6]. TGF-beta induces EMT by both Smad-dependent and -independent signaling events [4,7,8]. TGF-beta1 ligand exerts its signaling effects by activating a heteromeric receptor of two transmembrane serine/threonine kinases, type I and type II receptors (TbetaRI and TbetaRII) [7,9]. TbetaRII transphosphorylates TbetaRI, activating its kinase function. Activated TbetaRI then phosphorylates the intracellular proteins Smad2 and Smad3. The phosphorylated Smad2 and Smad3 associate with Smad4, with the activated complex translocating to the nucleus where it interacts with other transcriptional co-activators and co-repressors to regulate expression of numerous genes [10]. This Smad-dependent signaling up-regulates expression of several transcription factors important for EMT induction, including Snail, Slug, Twist, and members of the ZFH family, ZEB1 (also called EF1, TCF8, AREB6, ZFHEP, NIL-2A, ZFHX1A, and BZP) and ZEB2 (also called SIP1, SMADIP1, ZFHX1B, and KIAA0569) [11-13].
###end p 9
###begin p 10
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF8 </italic>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 697 702 <span type="species:ncbi:10090">mouse</span>
Of particular importance are ZEB1 and ZEB2 because they are crucial regulators of EMT during embryonic development and cancer [14,15]. These transcription factors activate EMT by binding to E-box elements present in the E-cadherin promoter, suppressing synthesis of this cell-cell adhesion protein [16,17]. ZEB1 also promotes EMT by repressing expression of basement membrane components and cell polarity proteins [13,14,18,19]. ZEB2 has also been implicated in the induction of EMT [13]. The loss of E-cadherin and other epithelial structural components is a major event during EMT. Mutations in the TCF8 gene (GenBank accession number ) result in a mesenchymal to epithelial transition (MET) in mouse embryos by reprogramming gene expression, leading to developmental defects by diminishing progenitor cell proliferation and cell migration [20]. Thus, it is crucial to understand the role of ZEB1 and ZEB2 in the reversal of TGF-beta-induced EMT.
###end p 10
###begin p 11
###xml 132 134 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 153 155 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 182 184 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 236 238 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 261 263 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 307 309 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 327 329 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 338 340 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 374 376 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 385 386 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 387 389 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 401 403 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 699 701 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 702 704 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Multiple signaling proteins in addition to Smads have been implicated in the induction of EMT by TGF-beta1. These include Ras/MAPK [21], integrin beta-1[22], integrin-linked kinase [23], p38 mitogen-activated protein kinase (p38 MAPK) [24], RhoA Kinase (ROCK) [25], phosphatidylinositol 3-OH kinase (PI3K) [26], Jagged1/Notch [27], SARA [28], nuclear factor kappa-B (NF-B) [29], Par6 [8,30], and ERK [31]. However, much less is known about how these signaling pathways and transcription factors maintain the mesenchymal program. Studies examining the reversal of EMT by perturbing one component of a signaling pathway with inhibitors or shRNAs demonstrate partial reversal of the mesenchymal state [32,33].
###end p 11
###begin p 12
Here, we report full reversal of EMT morphology and patterns of gene expression by concurrently inhibiting TbetaRI kinase and ROCK. We show that inhibition of TbetaRI kinase blocks mesenchymal gene expression, an effect mediated by down-regulation of ZEB1 and ZEB2 levels, while the ROCK inhibitor stabilizes the epithelial structure. These findings demonstrate that combined use of TbetaRI kinase and ROCK inhibitors is important to decrease TGF-beta signaling to enable full reversal of EMT.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
TGF-beta1 induces EMT in mTEC-KO cells
###end title 14
###begin p 15
###xml 146 148 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 414 416 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 661 663 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
We used primary mouse tubular epithelial cells isolated from the renal cortex of TGF-beta1 knockout mice (mTEC-KO cells) to model EMT in culture [34]. The mTEC-KO cells exhibit greater epithelial features than do wild-type renal epithelial cells. Renal tubular epithelial cells were chosen because of the correlation between the extent of tubulointerstitial fibrosis and the prognosis for end-stage renal disease [35]. In the absence of TGF-beta1, mTEC-KO cells form an epithelial sheet; incubation with 100 pM TGF-beta1 for 72 hours induced the mTEC-KO cells to acquire a more fibroblast-like, spindle shaped morphology indicative of mesenchymal cells (Figure 1A). Incubation with the TbetaRI inhibitor SB431542 blocked the TGF-beta1-induced transition of the mTEC-KO epithelial cells into mesenchymal cells. The morphological transformation correlated with major changes in the actin cytoskeleton as revealed by phalloidin staining. Untreated epithelial cells exhibited a cortical actin staining below the cell membranes, whereas the TGF-beta1-treated cells displayed elongated F-actin stress fibers. In the cells treated with the TbetaRI inhibitor SB431542, short, non-cortical actin fibers were detected.
###end p 15
###begin p 16
###xml 0 55 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;1 induces EMT in renal tubular epithelial cells</bold>
###xml 57 61 54 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 470 474 457 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 762 768 739 745 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C-E) </bold>
###xml 805 809 782 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C) </bold>
###xml 823 827 800 804 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D) </bold>
###xml 838 842 815 819 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E) </bold>
###xml 973 981 947 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt; 0.05</italic>
TGF-beta1 induces EMT in renal tubular epithelial cells. (A) Phase contrast (left) and Phalloidin staining (right) of mTEC-KO cells incubated for 72 hours as indicated without TGF-beta1, with 100 pM TGF-beta1, or with TGF-beta1 and 10 muM SB431542. Cell morphology was observed by bright field phase microscopy at 100x magnification. Phalloidin was used to detect F-actin at 400x magnification, while DAPI was used to detect nuclei. White arrows point to stress fibers. (B) Immunoblot showing protein expression of E-cadherin, alpha-SMA, and beta-tubulin following incubation of mTEC-KO cells with 100 pM TGF-beta1 for the indicated times. A dash indicates non-detectable levels of protein, while a plus sign indicates detectable protein levels over background. (C-E) show quantitative RT-PCR analysis of (C) Ksp-cadherin, (D) MMP-9, and (E) SM22 RNA levels in mTEC-KO cells incubated with TGF-beta1 for the indicated times. Asterisks (*) indicate significant differences (P < 0.05, n = 9).
###end p 16
###begin p 17
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 603 605 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
The structural integrity and polarization of epithelial cells is maintained by E-cadherins binding to catenins and a network of actin filaments; reduction of E-cadherin expression is a hallmark of mesenchymal acquisition [36]. Thus, we also examined the expression levels of several genes regulated by TGF-beta1 as markers for the epithelial and mesenchymal states. In mTEC-KO cells, incubation with TGF-beta1 led to a significant decrease in expression of the epithelial protein E-cadherin and increase in expression of the mesenchymal protein alpha-smooth muscle actin (alpha-SMA) by 72 hours (Figure 1B).
###end p 17
###begin p 18
###xml 345 347 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 348 350 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 451 453 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 578 580 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1D</xref>
###xml 639 641 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1E</xref>
###xml 773 781 767 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 782 784 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 785 787 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
Because TGF-beta1 is known to regulate expression of multiple cadherins, we also examined expression of Kidney-specific cadherin (Ksp-cadherin). Ksp-cadherin has a similar developmental pattern of expression as the tight junction proteins ZO-1 and claudin-3 in kidney epithelial cells; therefore, it is used as a marker of the epithelial state [37,38]. Incubation with TGF-beta1 led to a significant reduction in the level of Ksp-cadherin RNA (Figure 1C), while it led to significant increases in the RNA levels of mesenchymal markers matrix metalloproteinase-9 (MMP-9) (Figure 1D) and smooth muscle protein 22 (transgelin) (SM22) (Figure 1E). MMP-9 is an important extracellular matrix-degrading enzyme; SM22 has been shown to drive smooth muscle-specific gene expression in vivo [39-41]. Thus, we conclude that mTEC-KO cells completed the EMT program by several criterions following incubation with TGF-beta1.
###end p 18
###begin title 19
A combination of TbetaRI inhibitor with either ROCK or p38 MAPK inhibitors is required for complete EMT reversal
###end title 19
###begin p 20
###xml 466 468 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 469 471 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 472 474 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 475 477 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 534 536 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 537 539 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 908 910 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 986 987 967 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
To examine the reversibility of EMT induced by TGF-beta1 in mTEC-KO cells, we looked at the effects of five different kinase inhibitors targeting TbetaRI, p38 mitogen-activated protein kinase (p38 MAPK), MAP kinase kinase/extracellular signal-regulated kinase activator kinase (MEK1), c-Jun NH-terminal kinase (JNK), and Rho kinase (ROCK) with SB431542, SB203580, U0126, SP600125, and Y27632, respectively. These kinase inhibitors were previously implicated in EMT [24,31,42-44], 42-44 and their specificities have been well studied [45,46]. The cells were first incubated with 100 pM TGF-beta1 for 72 hours to induce EMT, the kinase inhibitors were then added, and incubation was continued for an additional 24 hours. Addition of TbetaRI inhibitor SB431542 at 5 muM for 24 hours was sufficient to reduce significantly the RNA level of the TGF-beta-responsive gene plasminogen activator inhibitor-1 (PAI-1) [47], demonstrating that TGF-beta1 signaling was effectively inhibited (Figure 2).
###end p 20
###begin p 21
###xml 0 161 0 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Treatment with a TR&#946;I inhibitor reverses PAI-1 RNA level in TGF-&#946;1-induced mesenchymal renal tubular epithelial cells to levels present in epithelial cells</bold>
###xml 466 468 453 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 469 473 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.05</italic>
Treatment with a TRbetaI inhibitor reverses PAI-1 RNA level in TGF-beta1-induced mesenchymal renal tubular epithelial cells to levels present in epithelial cells. mTEC-KOs were incubated with 100 pM TGF-beta1 ligand for 72 hours, followed by the addition of 5 muM SB431542 plus 100 pM TGF-beta1 for 24 hours. Cell lysates were prepared and relative PAI-1 RNA levels were determined by quantitative RT-PCR. Significant differences are indicated with an asterisk (*) (P <0.05, n = 9).
###end p 21
###begin p 22
###xml 191 192 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 251 252 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 397 399 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 614 618 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D-G</xref>
To assess the effects of the kinase inhibitors on EMT, the actin cytoskeleton was examined by phalloidin staining. In contrast to its ability to prevent induction of EMT by TGF-beta1 (Figure 1) and to reverse the elevation of PAI-1 expression (Figure 2), the TbetaRI inhibitor SB431542 failed to reverse the mesenchymal actin stress fiber morphology of the TGF-beta1-treated mTEC-KO cells (Figure 3C). Inhibition of other kinases previously implicated in inducing EMT, such as p38 MAPK, MEK1, JNK, and ROCK, also did not reverse the actin stress fiber morphology induced in the mTEC-KO cells by TGF-beta1 (Figures 3D-G). These results indicate that individual kinase inhibitors cannot fully reverse TGF-beta1-induced EMT in mTEC-KO cells.
###end p 22
###begin p 23
###xml 0 183 0 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Treatment of mTEC-KO cells with a T&#946;RI inhibitor and a ROCK inhibitor together, but not individually, reverses the mesenchymal actin cytoskeleton stress fibers induced by TGF-&#946;1</bold>
###xml 418 422 409 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 448 452 439 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 494 500 482 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C-G) </bold>
###xml 527 533 515 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H-K) </bold>
###xml 635 639 623 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C) </bold>
###xml 655 659 642 646 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D) </bold>
###xml 675 679 661 665 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E) </bold>
###xml 693 697 678 682 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F) </bold>
###xml 715 719 699 703 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G) </bold>
###xml 795 799 777 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H) </bold>
###xml 815 819 796 800 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(I) </bold>
###xml 833 837 813 817 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(J) </bold>
###xml 854 858 833 837 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(K) </bold>
###xml 875 879 853 857 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(L) </bold>
Treatment of mTEC-KO cells with a TbetaRI inhibitor and a ROCK inhibitor together, but not individually, reverses the mesenchymal actin cytoskeleton stress fibers induced by TGF-beta1. mTEC-KO cells were incubated with 100 pM TGF-beta1 for 72 hours, kinase inhibitors were added, and incubation was continued for an additional 24 hours. F-actin was visualized by staining with Texas Red-phalloidin. mTEC-KO cells were (A) untreated or treated with (B) 100 pM TGF-beta1 for 72 hours followed by (C-G) single kinase inhibitor or (H-K) SB431542 plus a second kinase inhibitor. Single kinase inhibitors and concentrations were as follows: (C) 5 muM SB431542, (D) 1 muM SB203580, (E) 1 muM Y27632, (F) 10 muM U0126, and (G) 15 muM SP600125. Combinations of kinase inhibitors were 5 muM SB431542 with (H) 1 muM SB203580, (I) 1 muM Y27632, (J) 10 muM U0126, or (K) 15 muM SP600125. (L) Combination of 5 muM Y27632 and 5 muM SB203580. White arrows point to stress fibers.
###end p 23
###begin p 24
###xml 247 251 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3H-K</xref>
###xml 359 361 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 362 364 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 543 545 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3H</xref>
###xml 550 552 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3I</xref>
###xml 627 629 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3H</xref>
###xml 898 900 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3I</xref>
###xml 1171 1173 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3J</xref>
###xml 1178 1180 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3K</xref>
###xml 1343 1345 1323 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3L</xref>
###xml 1645 1646 1618 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1884 1885 1854 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
Since EMT effects are mediated by multiple cellular pathways, we also tested pair wise combinations of inhibitors of TbetaRI (5 muM SB431542), p38 MAPK (1 muM SB203580), ROCK (1 muM Y27632), MEK1 (10 muM U0126), and JNK (15 muM SP600125) (Figures 3H-K). We chose to use low doses of the inhibitors to reduce the chance of non-specific small molecule binding [45,48]. When the TbetaRI inhibitor SB431542 was combined with either p38 MAPK inhibitor SB203580 or ROCK inhibitor Y27632 for 24 hours, the epithelial appearance was restored (Figures 3H and 3I). The TbetaRI inhibitor SB431542 plus p38 MAPK inhibitor SB203580 (Figure 3H) reduced the presence of stress fibers more than either treatment by itself. However, non-cortical actin filaments were still detectable. Detectable actin stress fibers were eliminated by the combination of TbetaRI inhibitor SB431542 and ROCK inhibitor Y27632 (Figure 3I). Cortical actin bordering the cell-cell junctions was restored by both combinations. The addition of either MEK1 inhibitor U0126 or JNK inhibitor SP600125 along with TbetaRI inhibitor SB431542 had no detectable effect on the mesenchymal phenotype of the cells (Figures 3J and 3K). The combination of p38 MAPK inhibitor SB203580 and ROCK inhibitor Y27632 restored cortical actin staining, but stress fiber actin remained in the cells (Figure 3L). Increasing the concentration of TbetaRI inhibitor SB431542 to 10 muM led to a further decrease in the level of stress fibers; however, the combination of TbetaRI inhibitor SB431542 with a p38 MAPK inhibitor SB203580 or ROCK inhibitor Y27632 was more effective at eliminating them (Additional File 1). Similar results were observed in wild-type mTEC cells, with a combination of TbetaRI inhibitor SB431542 and ROCK inhibitor Y27632 reversing EMT as indicated by both gene expression (data not shown) and cell morphology (Additional File 2). Collectively, these data indicate that treatment of the cells with TbetaRI inhibitor SB431542 by itself cannot lead to full re-acquisition of cortical actin at the cell junctions.
###end p 24
###begin p 25
###xml 396 397 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 402 404 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 568 570 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 1014 1016 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 1119 1121 1098 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 1126 1128 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 1424 1426 1403 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 1468 1470 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
###xml 1610 1612 1586 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4C</xref>
The effects of individual or combinations of kinase inhibitors on the expression of several genes altered by EMT were also examined by quantitative RT-PCR. The mTEC-KO cells were treated with 100 pM TGF-beta1 to transition into the mesenchymal state; afterward, the kinase inhibitors were added. Incubation with TGF-beta1 significantly reduced the Ksp-cadherin RNA level within 24 hours (Figures 1 and 4A). Addition of either TbetaRI inhibitor SB431542 or ROCK inhibitor Y27632 to the mesenchymal cells did not restore Ksp-cadherin RNA to pre-TGF-beta1-levels (Figure 4A). Incubation with p38 MAPK inhibitor SB203580 led to a further decrease in Ksp-cadherin expression. The combination of TbetaRI inhibitor SB431542 plus p38 MAPK inhibitor SB203580 was not effective in increasing the Ksp-cadherin RNA level, but addition of TbetaRI inhibitor SB431542 together with ROCK inhibitor Y27632 led to a much greater increase in the Ksp-cadherin RNA level than the level achieved with either inhibitor by itself (Figure 4A). TbetaRI inhibitor SB431542 efficiently reduced SM22 and MMP-9 expression to pre-EMT levels (Figures 4B and 4C). The p38 MAPK inhibitor SB203580 did not reduce either the SM22 or MMP-9 expression level, indicating that presence of this p38 MAPK inhibitor failed to reverse expression of these genes associated with the mesenchymal state. The ROCK inhibitor Y27632 partially reduced SM22 expression (Figure 4B), but increased MMP-9 expression (Figure 4C). This increase in MMP-9 expression was prevented by treatment with TbetaRI inhibitor SB431542 combined with ROCK inhibitor Y27632 (Figure 4C). Thus, we conclude that the TbetaRI inhibitor SB431542 by itself is sufficient to induce the accumulation of some transcripts specific to epithelial cells; however, the combination of TbetaRI and ROCK inhibitors can effectively induce the accumulation of certain additional epithelial-specific transcripts such as Ksp-cadherin that correlate with the full reversal of EMT.
###end p 25
###begin p 26
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Restoration of epithelial gene expression patterns requires a combination of kinase inhibitors</bold>
###xml 350 354 344 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 368 372 362 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 382 386 376 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C) </bold>
###xml 496 505 490 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 1) </bold>
###xml 541 550 532 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 2) </bold>
###xml 586 594 574 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lanes 3</bold>
###xml 595 598 583 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7) </bold>
###xml 630 638 618 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt; 0.05</italic>
Restoration of epithelial gene expression patterns requires a combination of kinase inhibitors. mTEC-KO cells were incubated with 100 pM TGF-beta1 for 72 hours to induce EMT. Afterward, they were incubated for an additional 24 hours with the indicated individual or combination of kinase inhibitors: 5 muM SB431542, 1 muM SB203580, and 1 muM Y27632. (A) Ksp-cadherin, (B) SM22, and (C) MMP-9 mRNA levels were determined by quantitative RT-PCR. Significant differences between the untreated cells (lane 1) versus cells treated with TGF-beta1 (lane 2) or TGF-beta1 followed by inhibitors (lanes 3-7) are indicated by asterisks (*) (P < 0.05, n = 9).
###end p 26
###begin p 27
###xml 329 330 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 384 386 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5C</xref>
###xml 419 421 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5D</xref>
###xml 463 465 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5E</xref>
###xml 587 589 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B</xref>
###xml 692 694 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5G</xref>
###xml 729 731 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5H</xref>
###xml 857 859 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 899 901 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5F</xref>
###xml 986 988 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5I</xref>
###xml 1274 1276 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5J</xref>
One important criterion for epithelium restoration is re-expression of the cell-cell junction adhesion protein E-cadherin. To test for this factor, we incubated mTEC-KO cells with 100 pM TGF-beta1 for 72 hours to induce EMT, added the indicated kinase inhibitors, and continued incubation for an additional 24 - 48 hours (Figure 5). Addition of the TbetaRI inhibitor SB431542 (Figure 5C), ROCK inhibitor Y27632 (Figure 5D), or p38 MAPK inhibitor SB203580 (Figure 5E) by itself led to partial reformation of E-cadherin at cell junctions compared to the TGF-beta1-treated-mTEC-KOs (Figure 5B). Addition of the TbetaRI inhibitor SB431542 together with either p38 MAPK inhibitor SB203580 (Figure 5G) or ROCK inhibitor Y27632 (Figure 5H) restored E-cadherin localization to a level indistinguishable from that observed in the non-TGF-beta1-treated cells (Figure 5A). JNK inhibitor SP600125 alone (Figure 5F) or a combination of TbetaRI inhibitor SB431542 plus JNK inhibitor SP600125 (Figure 5I) did not restore either the level or localization of E-cadherin. The combination of TbetaRI inhibitor SB431542 plus ROCK inhibitor Y27632 was most effective in restoring both localization of E-cadherin and its protein level as determined by immunoblot analysis of cell lysates (Figure 5J). Thus, we conclude that the TbetaRI, p38 MAPK, and ROCK inhibitors increase E-cadherin levels; however, the combination of the TbetaRI inhibitor with p38 MAPK or ROCK inhibitor is most effective.
###end p 27
###begin p 28
###xml 0 127 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E-cadherin expression is restored by combined treatment with a T&#946;RI kinase inhibitor and either a ROCK or p38 MAPK inhibitor</bold>
###xml 129 133 126 130 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-I </bold>
###xml 327 331 321 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 356 360 350 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 430 434 421 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C) </bold>
###xml 450 454 440 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D) </bold>
###xml 470 474 459 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E) </bold>
###xml 491 495 479 483 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F) </bold>
###xml 558 562 544 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G) </bold>
###xml 578 582 563 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(H) </bold>
###xml 599 603 583 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(I) </bold>
###xml 620 624 603 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(J) </bold>
E-cadherin expression is restored by combined treatment with a TbetaRI kinase inhibitor and either a ROCK or p38 MAPK inhibitor. A-I Phase contrast microscopy of mTEC-KO cells incubated for 72 hours with 100 pM TGF-beta1 followed by the indicated inhibitor(s) for an additional 36 hours prior to fixing and staining with DAPI. (A) untreated control cells; (B) treated only with TGF-beta1; treated individually with the inhibitors (C) 5 muM SB431542, (D) 5 muM SB203580, (E) 5 muM Y27632, or (F) 15 muM SP600125; and treated together with 5 muM SB431542 plus (G) 5 muM SB203580, (H) 5 muM Y27632, or (I) 15 muM SP600125. (J) Immunoblot analysis of cell lysates obtained from the above-treated mTEC-KOs for the presence of E-cadherin. beta-tubulin served as a control.
###end p 28
###begin title 29
Reduction in ZEB1 levels is necessary for EMT reversal by TbetaRI inhibitor
###end title 29
###begin p 30
###xml 144 146 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 165 166 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 221 223 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 326 328 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 329 331 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 332 334 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 335 337 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 795 797 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 798 800 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 904 906 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1048 1049 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1163 1164 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1294 1296 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1405 1407 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1408 1410 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 830 836 <span type="species:ncbi:10090">Murine</span>
In the next series of experiments, we decided to examine the effects of ZEB1 and ZEB2 levels because their expression is regulated by TGF-beta [13] (Additional File 3) and they are highly expressed in fetal kidney cells [49]. ZEB1 and ZEB2 can also play an important role in EMT induction by repressing E-cadherin expression [13,15,50-57]. Our data presented above led us to hypothesize that decreasing expression of transcriptional EMT regulators such as ZEB1 and ZEB2 is not sufficient for complete EMT reversal; rather, the presence of a ROCK inhibitor is also necessary to decrease mesenchymal structural components such as stress fibers. Historically, the effects of ZEB1 and ZEB2 have been studied in non-proximal tubule kidney cell lines such as Maderin Darby Canine Kidney (MDCK) cells [56,58]. We chose here to use Namru Murine Mammary gland (NMuMG) cells, a traditional EMT cell culture model [59], because: (i) NMuMG cells are easier to manipulate than mTEC-KO cells; (ii) they contain a readily detectable level of ZEB1 protein (Figure 6); (iii) we could only assay expression of ZEB1 and ZEB2 in mTEC-KO cells by quantitative RT-PCR (Additional File 3), not immunoblotting (data not shown); and (iv) RNA levels do not necessarily well reflect the protein levels of ZEB1 and ZEB2 ([60] A.L. Ellis & J.E. Mertz unpublished data) since ZEB1 and ZEB2 are highly regulated post-transcriptionally [55,56].
###end p 30
###begin p 31
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Restoration of E-cadherin expression in NMuMG cells is dependent on levels of ZEB1 and ZEB2</bold>
###xml 265 273 262 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 3)</bold>
###xml 291 299 287 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 4)</bold>
###xml 315 323 310 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 5)</bold>
###xml 365 373 358 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 6)</bold>
###xml 558 566 546 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 7)</bold>
###xml 590 598 575 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 8)</bold>
###xml 643 651 624 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(lane 9)</bold>
Restoration of E-cadherin expression in NMuMG cells is dependent on levels of ZEB1 and ZEB2. NMuMG cells were incubated for 48 hours with 100 pM TGF-beta1 to induce EMT. Thereafter, the cells were incubated for an additional 24 hours with the indicated inhibitors: (lane 3), 1 muM SB431542; (lane 4), 1 muM Y27632; (lane 5), 1 muM SB431542 and 10 muM SP600125; and (lane 6), 1 muM SB431542 and 1 muM Y27632. NMuMG cells were also infected with shRNAmir-targeting ZEB1 and ZEB2 lentiviruses followed by incubation for an additional 24 hours without TGF-beta1 (lane 7), with 100 pM TGF-beta1 (lane 8), or with 100 pM TGF-beta1 plus 1 muM Y27632 (lane 9). Levels of ZEB1, ZEB2, E-cadherin, and beta-actin protein in the cells were assessed by immunoblot analysis. Dash indicates protein present at level below background; plus sign indicates protein present at clearly detectable level. Similar findings were observed in two other independent experiments.
###end p 31
###begin p 32
###xml 185 186 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 290 291 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 448 449 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 567 568 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 696 697 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 967 968 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
NMuMG cells were incubated with 100 pM TGF-beta1 for 48 hours to induce EMT, the indicated kinase inhibitors were added, and incubation was continued for an additional 24 hours (Figure 6). Treatment of NMuMG cells with TGF-beta1 led to a small increase in the level of ZEB1 protein (Figure 6, lane 2). Following incubation with TbetaRI inhibitor SB431542, the level of ZEB1 protein decreased back down to the level of untreated NMuMG cells (Figure 6, lane 3). Incubation with ROCK inhibitor Y27632 by itself led to a significant increase in the level of ZEB1 (Figure 6, lane 4); however, if cells treated with the ROCK inhibitor Y27632 were also incubated with TbetaRI inhibitor SB431542 (Figure 6, lane 6), the level of ZEB1 decreased to the level of untreated cells. ZEB2 protein was difficult to detect with our antibody; nevertheless, we could readily detect ZEB2 protein in the cells incubated with TbetaRI inhibitor SB431542 plus JNK inhibitor SP600125 (Figure 6, lane 5), indicating this combination of inhibitors led to increased expression of ZEB2 even if not ZEB1. From these results, we conclude that incubation with TbetaRI inhibitor can reverse the increase in ZEB1 levels.
###end p 32
###begin p 33
###xml 253 254 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 327 328 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 422 423 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 552 553 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 684 685 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 825 826 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 945 946 924 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
We next tested whether the decrease in ZEB1 level by kinase inhibitors restored E-cadherin expression in NMuMG cells treated with TGF-beta. Similar to our findings in the mTEC-KO model system, incubation with TGF-beta1 led to loss of E-cadherin (Figure 6, lane 2). Incubation with either the TbetaRI inhibitor SB431542 (Figure 6, lane 3) or the TbetaRI inhibitor SB431542 in combination with ROCK inhibitor Y27632 (Figure 6, lane 6) restored the E-cadherin level. ROCK inhibitor Y27632 alone was not effective in restoring the E-cadherin level (Figure 6, lane 4). E-cadherin was also not restored in cells incubated with TbetaRI inhibitor SB431542 plus JNK inhibitor SP600125 (Figure 6, lane 5). Although the ZEB1 level was similar to the cells incubated with the TbetaRI inhibitor SB431542 and ROCK inhibitor Y27632 (Figure 6, lane 6), the cells incubated with TbetaRI inhibitor SB431542 plus JNK inhibitor SP600125 also expressed ZEB2 (Figure 6, lane 5) which could account for the observed repression of E-cadherin expression. These data indicate that inhibition of the TGF-beta-induced increase in ZEB1 levels can lead to re-expression of E-cadherin. However, the re-expression of E-cadherin can be inhibited if ZEB2 is expressed.
###end p 33
###begin p 34
###xml 382 383 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 579 581 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 650 651 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 793 794 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 914 915 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
To test whether ZEB1 and ZEB2 levels directly affect E-cadherin expression, we performed RNA-mediated interference experiments. NMuMG cells infected with lentiviruses expressing a pool of individual ZEB1 and ZEB2 shRNAs knocked down endogenous expression of ZEB1 to a nearly undetectable level within 72 hours regardless of whether the cells had been treated with TGF-beta1 (Figure 6, lanes 7-9). Although ZEB2 protein was not detected by our assay in these cells, we included shRNAs targeting ZEB2 because others reported detection of ZEB2 RNA in TGF-beta1 treated NMuMg cells [13]. While incubation with TGF-beta1 led to loss of E-cadherin (Figure 6, lane 2), this treatment with ZEB1 plus ZEB2 shRNAs restored E-cadherin to levels that were higher as compared to the original cells (Figure 6, lane 8). ZEB depletion together with incubation with 1 muM Y27632 also led to increased E-cadherin expression (Figure 6, lane 9). Thus, we conclude that depletion of ZEB by either shRNAs or kinase inhibitors is sufficient to re-introduce E-cadherin expression in TGF-beta-induced mesenchymal cells.
###end p 34
###begin title 35
ZEB1 depletion combined with ROCK inhibitor Y27632 is required to complete the EMT reversal program by eliminating stress fibers
###end title 35
###begin p 36
###xml 201 203 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7B</xref>
###xml 418 420 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7C</xref>
###xml 556 557 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 761 763 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7D</xref>
###xml 931 933 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7E</xref>
Loss of E-cadherin is accompanied by rearrangement of the actin cytoskeleton to maintain polarized cell structure. NMuMG cells treated with TGF-beta exhibit stress fibers and lower cell number (Figure 7B). Thus, we also examined the effect of ZEB level on the arrangement of F-actin stress fibers in NMuMG cells. Treatment of the cells with shRNAs against ZEB1 and ZEB2 led to attenuation of the stress fibers (Figure 7C); however, the arrangement of F-actin did not completely reverse as compared to the cells incubated with the kinase inhibitors (Figure 3). On the other hand, NMuMG cells treated with TGF-beta and incubated with ROCK inhibitor Y27632 together with the ZEB shRNAs exhibited decreased F-actin fibers and reappearance of cortical actin (Figure 7D). This failed to occur when TGF-beta-treated cells infected with the viruses expressing the shRNAs against the ZEBs were incubated with JNK inhibitor SP600125 (Figure 7E). Taken together, these data indicate that ROCK inhibitor Y27632 treatment leads to stabilization of cortical actin, while reduction in expression of the ZEBs leads to increased expression of factors such as E-cadherin necessary for EMT reversal.
###end p 36
###begin p 37
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZEB1 and ZEB2 depletion by shRNAs in NMuMG cells attenuates F-actin stress fibers</bold>
ZEB1 and ZEB2 depletion by shRNAs in NMuMG cells attenuates F-actin stress fibers. Cells were treated as indicated with 100 pM TGF-beta1 for 48 hours followed by an additional 72 hour incubation with a lentivirus encoding pLKO.1 (a control shRNA) or lentiviruses encoding shRNAs against ZEB1 and ZEB2, with 1 muM Y27632 or 10 muM SP600125 added during the last 24 hour incubation with the shRNAs. F-actin was visualized by phalloidin. Cells were viewed at a 400x magnification. White arrows point to stress fibers.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 216 217 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 331 332 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 334 335 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 337 338 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 340 341 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 520 521 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 625 628 613 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g</italic>
###xml 957 958 942 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1166 1167 1148 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
The goal of this study was to elucidate molecular mechanisms involved in maintaining the mesenchymal state induced by TGF-beta1. Here, we demonstrated that preventing EMT requires blocking the TbetaRI kinase (Figure 1), while reversing the EMT program is more complex, requiring inhibition of both TbetaRI kinase and ROCK (Figures 3, 4, 5, 6). A p38 MAPK inhibitor also plays a role by working in conjunction with the TbetaRI kinase inhibitor to further lessen the mesenchymal structural elements to reverse EMT (Figure 3). We defined the success of an agent in reversing EMT as the re-expression of key epithelial proteins (e.g., E-cadherin, cortical actin) and the re-positioning of these proteins to allow for epithelial cell morphology. We also demonstrated that reversal of EMT by the TbetaRI inhibitor SB431542 involves, in part, inhibiting expression of ZEB1, a key transcriptional repressor of E-cadherin expression and the epithelial state (Figure 6). Taken together, these findings indicate that TGF-beta maintains the mesenchymal phenotype through sustained activation of Smad-dependent transcriptional responses and elements downstream from ROCK (Figure 8).
###end p 39
###begin p 40
###xml 0 46 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Model for reversal of EMT induced by TGF-&#946;1</bold>
###xml 184 187 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g</italic>
Model for reversal of EMT induced by TGF-beta1. To re-express epithelial proteins such as E-cadherin, a TbetaRI kinase inhibitor is needed to decrease expression of mesenchymal genes (e.g., ZEB1 and ZEB2), while a Rho kinase inhibitor is required to stabilize the epithelial cortical actin. A p38 MAPK inhibitor may also be useful as this drug in conjunction with the TbetaRI kinase inhibitor can further EMT reversal by reducing stress fiber actin formation.
###end p 40
###begin title 41
Decreasing ZEB1 and ZEB2 expression enables partial re-programming of EMT by inducing E-cadherin expression
###end title 41
###begin p 42
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 801 802 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
The levels of ZEB1 and ZEB2 can regulate the epithelial transition to the mesenchymal state, [51-56,60,61]. In Madin-Darby Canine Kidney (MDCK) cells, EMT is preceded by the loss of mature miR200a-c, inducing up-regulation of ZEB1 and ZEB2 expression followed by loss of E-cadherin expression and transition to the mesenchymal state [50,59,62,63]. In cancers or fibrosis, this feedback loop may be disrupted, leading to unregulated expression of ZEB1 or ZEB2. To regain this feedback loop, a small molecule inhibitor of TbetaRI may be useful to block factors maintaining the mesenchymal state. In this case, blocking the feedback loop during TGF-beta1-induced maintenance of ZEB1 levels might enable re-expression of miRNA200 family members and proteins involved in epithelial cell morphology (Figure 8).
###end p 42
###begin p 43
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Thuault et al. [33] previously examined the role of Snail, another E-box-binding transcriptional repressor of E-cadherin gene expression, in EMT reversal. They reported that High Mobility Group A2 (HMGA2) sustains TGF-beta-induced EMT in NMuMG cells, with partial EMT reversal occurring as measured by restoration of tight junction proteins and a partial restoration of cortical actin when Snail is targeted for depletion by shRNA. However, E-cadherin did not re-colocalize or become expressed at cell-cell junctions, indicating that either Snail was not sufficiently knocked down in their experiment or there was another factor regulating localization of the cytoskeleton components.
###end p 43
###begin p 44
###xml 227 228 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 233 234 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 471 472 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
Our studies demonstrate that depleting mesenchymal cells of ZEB1 and ZEB2 with specific shRNAs or using a TRbetaI inhibitor in combination with a ROCK inhibitor is sufficient to restore fully E-cadherin protein levels (Figures 6 and 7). However, solely targeting ZEB1 and ZEB2 with shRNAs did not lead to full restoration of cortical actin at the cell borders; rather, treatment as well with a ROCK inhibitor was necessary for complete reduction of stress fibers (Figure 7). Other factors may also be necessary to maintain the epithelial cytoskeleton.
###end p 44
###begin title 45
ROCK regulates the cytoskeleton during EMT reversal to stabilize the epithelial structure
###end title 45
###begin p 46
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1193 1195 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 1196 1198 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1274 1276 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
One plausible regulator of the actin cytoskeleton is Rho. Here, we showed that ROCK is responsible for only a subset of EMT changes, such as actin rearrangement (Figures 3 and 7). Inhibiting ROCK was not sufficient to induce E-cadherin or other epithelial characteristics (Figures 3, 4, 5, 6). This finding implies that ROCK is necessary for epithelial cells to regain cytoskeletal structure. We hypothesize that re-acquisition of the epithelial cytoskeleton might sequester the mesenchymal signaling associated with the unformed cell-cell adhesions [64]. In mammary gland epithelial cells, Rho location is controlled by the partitioning-defective protein 6C (Par6), a regulator of the polarity complex [8]. When TbetaRII is activated, Par6 is phosphorylated and recruits the E3 ubiquitin ligase Smurf1 to the cell membrane, thereby regulating the localization of Rho by ubiquitination. This implies that the location of Rho is important for the arrangement of actin in epithelial cells. To determine the mechanism of TGF-beta activation of stress fibers, further studies are needed to examine if TGF-beta induces F-actin stress fibers as the result of ROCK activating LIM kinase and cofilin [65,66] or by ROCK regulating gene expression through Jak-Stat and NF-B pathways [67].
###end p 46
###begin title 47
Temporal control of EMT reversal varies with the agents and cell type
###end title 47
###begin p 48
###xml 362 364 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 930 932 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 933 935 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 1155 1156 1143 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1161 1162 1149 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
Other reports of mesenchymal phenotypic reversion utilizing inhibitors have claimed various degrees of success. For example, EMT induced in EpH4 mouse mammary epithelial cells by an estradiol-inducible c-Fos-estrogen receptor fusion protein was only partially reversed after 3 - 6 days of incubation with BIBU 3029, a small molecule inhibitor of TbetaRI kinase [68]. However, ectopic expression of E-cadherin combined with addition of BIBU 3029 did lead to full reversal of the EpH4 mesenchymal cells as assayed by the formation of cobblestone-like epithelial sheets with tight junctions between the cells and localized expression of E-cadherin and beta-catenin at cell junctions, but only after 6 days. Others have reported that incubation with individual inhibitors of TbetaRI kinase is sufficient to increase E-cadherin expression and to induce a more epithelial morphological appearance within 48 hours in several cell lines [69-71]. By contrast, our study showed that a combination of a TbetaRI inhibitor and a ROCK inhibitor can enable complete, rapid reversal of EMT within 24 hours, including re-expression of Ksp-cadherin and E-cadherin (Figures 4 and 5). Plausible explanations for the differences in our observations include (i) the agents employed to induce EMT, and (ii) the specific cell types used in the experiments.
###end p 48
###begin title 49
Chemical inhibition of JNK blocks EMT reversal by the TbetaRI inhibitor
###end title 49
###begin p 50
###xml 189 190 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 192 193 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 195 196 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 198 199 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 349 351 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 488 490 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 637 639 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 743 745 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B74">74</xref>
###xml 873 875 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
Our studies demonstrate that small molecule inhibition of JNK can block the reversal effects of the TbetaRI inhibitor by maintaining stress fibers and decreasing E-cadherin levels (Figures 3, 5, 6, 7). Suppression of JNK leads to increased expression of the transcription factor Slug in trophoblast stem cells, leading to induction of an EMT state [72]. Like ZEB1 and ZEB2, Slug induces EMT by repressing expression of E-cadherin via binding to E-box elements in the E-cadherin promoter [73]. Another plausible explanation for maintenance of non-TGF-beta-dependent EMT is that the JNK inhibitor may activate other pathways such as NF-B [29]. Previous studies demonstrated NF-B both suppresses apoptosis and induces EMT in breast cancer cells [74]. NF-B has been shown to induce EMT by upregulating E-cadherin transcriptional repressors such as Snail, Slug, ZEB1, and ZEB2 [29]. This indicates that a JNK inhibitor should not be used in conjunction with a TbetaRI inhibitor as doing so may compromise EMT reversal.
###end p 50
###begin title 51
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Inhibitors in combination may be a feasible therapeutic approach for treating patients with EMT-associated diseases
###end title 51
###begin p 52
###xml 267 268 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 682 687 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 823 825 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B75">75</xref>
###xml 920 922 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 923 925 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 926 928 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 929 931 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B76">76</xref>
###xml 932 934 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B77">77</xref>
###xml 1058 1060 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B78">78</xref>
###xml 1273 1275 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B79">79</xref>
###xml 1276 1278 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B80">80</xref>
###xml 1404 1406 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B81">81</xref>
###xml 1407 1409 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B82">82</xref>
###xml 1239 1247 <span type="species:ncbi:9606">patients</span>
###xml 1507 1515 <span type="species:ncbi:9606">patients</span>
In chronic fibrotic diseases, reversal of the mesenchymal state generated by EMT may be critical for restoring function to organs. For example, it might provide a potential therapy for treating chronic kidney damage caused by constitutively high levels of TGF-beta1 [3]. Blocking EMT is useful for preventative medicine. However, reversing EMT holds more promise for treating existing diseases. Our use of small molecule inhibitors of individual protein kinases not only demonstrates their potential for dissecting mechanisms of signal transduction for specific ligands and for delineating their roles in biologic responses, but also their potential as therapeutic agents. Yingling et al. have described a group of competitive ATP-binding site inhibitors of ALK-5 as possible agents for treating some cancers and fibrosis [75]. In certain cancers, treatment with a TbetaRI inhibitor shows promise in halting metastasis [33,68-70,76,77]. Therapeutics in the form of growth factors such as BMP-7 can also act as TGF-beta antagonists to treat fibrotic disease [78]. Other approaches to block TGF-beta activity, such as anti-sense DNA targeting TGF-beta, are in clinical trials as a vaccine against tumor cells or as therapeutics for treating patients with high-grade gliomas [79,80]. In addition, ROCK and p38 MAPK inhibitors are in clinical trials as potential therapeutics targeting a variety of cancers [81,82]. These recent developments suggest multiple therapeutic strategies may be possible for treating patients with diseases in which TGF-beta-induced EMT contributes to the pathology.
###end p 52
###begin title 53
Conclusion
###end title 53
###begin p 54
###xml 336 337 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8</xref>
We showed here that reversing EMT in mTEC-KO cells requires inhibition of both TbetaRI kinase and ROCK. The TbetaRI kinase inhibitor decreased expression of ZEB1 and ZEB2, thereby increasing expression of the epithelial protein E-cadherin, and the ROCK inhibitor was necessary to fully eliminate mesenchymal actin stress fibers (Figure 8).
###end p 54
###begin title 55
Methods
###end title 55
###begin title 56
Cells and Reagents
###end title 56
###begin p 57
###xml 568 569 565 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1084 1086 1072 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 45 51 <span type="species:ncbi:10090">murine</span>
###xml 123 129 <span type="species:ncbi:10090">murine</span>
###xml 447 453 <span type="species:ncbi:9913">bovine</span>
###xml 664 670 <span type="species:ncbi:10090">murine</span>
Early passage (passage 2) TGF-beta1 knockout murine renal tubular epithelial cells (mTEC-KO) and early passage (passage 5) murine renal tubular epithelial cells (mTEC-WT) were generously provided to us by Dr. Jeffrey Kopp (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD). The cells were grown until passage 20. They were maintained in Renal Epithelial Cell Growth Medium (Cambrex, MD) supplemented with 0.25% fetal bovine serum (FBS), a Bullet Kit that contained epidermal growth factor, insulin, hydrocortisone, GA-1000, epinephrine, T3, and transferrin (Cambrex, NJ), and penicillin and streptomycin (Gibco-Invitrogen, CA). Namru murine mammary gland (NMuMG) cells were obtained from Dr. Caroline Alexander (UW-Madison, WI). They were grown in DMEM supplemented with 10% FBS, 10 mug/ml insulin, 100 mug/ml penicillin, and 100 U/ml streptomycin. 293T cells were purchased from ATCC (VA). They were grown in 10% DMEM supplemented with 10% FBS, 100 mug/ml penicillin, and 100 U/ml streptomycin. All cells were maintained in a 37degreesC humidified 5% CO2 incubator. Carrier-free TGF-beta1 was obtained from R&D Systems (MN). Chemical inhibitors SB203580, SP600125, and Y27632 (Calbiochem, CA); SB431542 (Sigma, MO); and U0126 (Promega, WI) were aliquoted after reconstitution and frozen at -80degreesC.
###end p 57
###begin title 58
Production of Lentiviruses
###end title 58
###begin p 59
###xml 571 573 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B83">83</xref>
The lentiviral shRNAmir vectors targeting ZEB1 (target set NM_011546), ZEB2 (target set NM_014795), and control pLKO.1 (RHS4080) were purchased from OpenBiosystems (Thermo Scientific, AL). Plasmid pLKO.1 contains a scrambled sequence that results in synthesis of a shRNA that does not appear to inhibit expression of any known cellular gene. To generate virus, mycoplasma-free 293T cells were transfected using LT1 (Mirus, WI) with 10 mug total of a mixture containing shRNAmir ZEB1 and ZEB2 or pLKO.1 as indicated, 3 mug lentiviral DNA encoding Gag/Pol, and 1 mug VSVG [83] (provided by Dr. Bill Sugden, Madison, WI). The medium was supplemented with 50 mM HEPES solution, pH 7.3 (Invitrogen) and changed after 6 hours. Viral supernatant was collected after 24 hours and passed through a 0.45 mum filter. NMuMG cells were infected daily with the pool of shZEB1 and shZEB2 viruses over 48 - 72 hours to decrease ZEB1 and ZEB2 expression.
###end p 59
###begin title 60
Immunoblotting
###end title 60
###begin p 61
###xml 1039 1044 <span type="species:ncbi:10090">mouse</span>
###xml 1065 1076 <span type="species:ncbi:3704">horseradish</span>
After treatment as indicated, cells were washed with cold PBS, lyzed in TNE buffer [50 mM Tris-HCl (pH 8.0), 1% NP40, 150 mM NaCl, 5 mM EDTA] and pelleted by centrifugation at 14,000 rpm for 5 min at 4degreesC. Lysates were prepared using TNE buffer supplemented with protease inhibitor cocktail (Roche, NJ) and protease inhibitor cocktail solution III (Calbiochem, CA). Cell homogenates were incubated for 10 min at 100degreesC in 2x loading buffer. Equal amounts of protein, as assessed by BCA Protein Assay Kit (BioRad, CA), were added to each well. The proteins were separated by electrophoresis in 4% - 20% gradient polyacrylamide gels (ISC BioExpress, UT) and transferred to PVDF membranes (Millipore, MA) or nitrocellulose filters (ISC Biosystem, UT). The primary antibodies used for detection were as follows: E-cadherin (BD Biosciences, CA), ZEB1 (H102, Santa Cruz Biotechnology, CA), ZEB2 (Dr. Michel Sanders, University of Minnesota, MN; purified by Dr. Xianming Yu, UW-Madison, WI), and alpha-Smooth Muscle Actin (Sigma). Anti-mouse IgG conjugated with horseradish peroxidase (Millipore) was used as the secondary antibody. Blots were developed by ECL (GE Healthcare, NJ). Where indicated, the immunoblots were stripped by incubation with 100 mM beta-mercaptoethanol, 2% SDS, 62.5 mM TRIS (pH 8.2) at 65degreesC for 1 hour and reprobed with beta-actin (Sigma) or beta-tubulin (Sigma) primary antibody as indicated and HRP secondary antibody (GE Healthcare). Relative protein levels were determined by densitometry using Bio-Rad Quantity One Software (Bio-Rad), with normalization to the amount of cellular beta-actin or beta-tubulin present in each sample. Changes in the amount of a protein present in an experimental sample are shown relative to the amount of this protein present in the untreated control sample processed in parallel.
###end p 61
###begin title 62
Quantitative RT-PCR
###end title 62
###begin p 63
###xml 766 768 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 793 794 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">'</sup>
###xml 818 819 817 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">'</sup>
###xml 830 831 829 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">'</sup>
###xml 857 858 856 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">'</sup>
###xml 942 944 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B84">84</xref>
###xml 1688 1690 1675 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B85">85</xref>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 393 398 <span type="species:ncbi:10090">mouse</span>
###xml 440 445 <span type="species:ncbi:10090">mouse</span>
###xml 523 528 <span type="species:ncbi:10090">mouse</span>
###xml 771 776 <span type="species:ncbi:10090">mouse</span>
After treatment as indicated, total RNA was isolated from the cells using RNAeasy Miniprep kit (Qiagen) and quantified by UV spectrophotometer. 1.5 mug of RNA from each sample was converted by reverse transcriptase into cDNA using an OmniScript kit (Qiagen). Primers used for qRT-PCR were as follows: mouse Ksp-cadherin: forward-5'-CTGCACACAGAAGTCCCTGA-3', reverse 5'-CCTTGTCGCCACTAGAAAGC-3'; mouse MMP-9: SuperArray primer (MD) PPM03661A; mouse SM22: forward 5'-GCAGTCCAAAATTGAGAAGA-3', reverse 5'-CTGTTGCTGCCCATTTGAAG3'; mouse PAI-1: forward 5'-TTCAGCCCTTGCTTGCCTC-3', reverse 5'-ACACTTTTACTCCGAAGTCGGT-3'; ZEB1: forward 5'-AACGGAGATTTGTCTCCCAGT-3', reverse 5'-CTGTCCAGCTTGCATCTTTTC-3'; ZEB2: forward 5'-TAGCCGGTCCAGAAGAAATG-3', reverse 5'-GGCCATCTCTTTCCTCCAGT-3'[20]; mouse GAPDH: forward 5'-AGGTCGGTGTGAACGGATTTG-3', reverse 5'-TGTAGACCATGTAGTTGAGGTCA-3'; and P0: forward, 5'-GACAATGGCAGCATCTACAAC-3', reverse, 5'-GCAGACAGACACTGGCAAC-3' [84]. cDNA was amplified in an Opticon 2 PCR machine (MJ Research) and labelled using an ABI SYBR Green qPCR Kit (ABI Systems, CA). The amplifications were carried out in the following manner: initial denaturation for 10 min at 95C, denaturation for 10 sec at 95degreesC, annealing for 30 sec at an optimal temperature for each cDNA, and extension for 30 sec at 72degreesC. Standards were created from Pfu (Stratagene, CA)-amplified PCR products purified by gel electrophoresis. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control to normalize gene expression levels, except for ZEB1 and ZEB2 where the ribosomal protein P0 was used, instead. Relative ZEB1 and ZEB2 RNA levels were calculated by a modified Ct method [85].
###end p 63
###begin title 64
Immunofluorescence
###end title 64
###begin p 65
###xml 314 318 <span type="species:ncbi:9925">goat</span>
###xml 529 533 <span type="species:ncbi:9925">goat</span>
###xml 594 598 <span type="species:ncbi:9925">goat</span>
Cells were seeded on glass cover slips (Fisher, PA) or 8-well chamber slides (Fisher) and cultured as described. Afterward, the cells were fixed by incubation in 4% paraformaldehyde for 5 min and permeabilized in PBS containing 0.1% Triton X-100 for 10 min. Non-specific binding was blocked with 10% BSA or normal goat serum for 30 min. F-actin was stained at a 1:1000 dilution in 2% BSA of Texas Red-conjugated or FITC-conjugated phalloidin (Sigma) for at least 30 min. E-cadherin (BD Biosciences) was diluted 1:50 in 2% normal goat serum and incubated overnight. A secondary antibody made in goat (Invitrogen) was used at a 1:1000 dilution and incubated for 2 hours in a humid chamber with minimal exposure to light. All washes were done in 1x PBS. An anti-fade solution containing DAPI (Vector Laboratories, CA) was used in mounting the slides. Images were taken at room temperature with an Axiocam digital camera attached to a Zeiss microscope. Axiovision was used to acquire the image. Adobe Photoshop was used to merge images.
###end p 65
###begin title 66
Statistical Analysis
###end title 66
###begin p 67
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
Unless indicated otherwise, all experiments were performed on three separate occasions, each time with triplicates, with the figures showing means of the triplicates for one of the experiments (n = 3). For statistical evaluation, the data from all experimental replicates were pooled (n = 9). For comparisons between pairs, we used one-way analysis of Wilcoxson Rank Sums determined with MSTAT software . A p value < 0.05 was considered statistically significant.
###end p 67
###begin title 68
Abbreviations
###end title 68
###begin p 69
###xml 206 212 <span type="species:ncbi:10090">murine</span>
###xml 261 266 <span type="species:ncbi:10090">mouse</span>
###xml 329 335 <span type="species:ncbi:10090">murine</span>
EMT: epithelial to mesenchymal transition; Ksp-cadherin: kidney specific cadherin; JNK: c-Jun NH-terminal kinase; MEK1: MAPK/extracellular signal-regulated kinase; MMP-9: matrix metalloprotease-9; mTEC-KO: murine tubular epithelial cells from TGF-beta knockout mouse; p38 MAPK: p38 mitogen-activated protein kinase; NMuMG: Namru murine mammary gland; ROCK: Rho kinase; SM22: smooth muscle protein 22; alpha-SMA: alpha smooth muscle actin; TGF-beta: Transforming Growth Factor beta; TbetaRI: Transforming Growth Factor-beta Receptor Type I.
###end p 69
###begin title 70
Authors' contributions
###end title 70
###begin p 71
SD and FMH designed and planned the experiments and analyzed the data for the inhibitor studies. SD and JEM designed and planned the experiments for the ZEB studies. SD carried out all of the experimental work, analyzed the data, and prepared the manuscript. FMH and JEM edited the manuscript. All authors read and approved the final manuscript. FMH and JEM supervised the overall conduct of the research and provided funding. BNB provided mTEC-KO cells, mTEC-WT cells, expertise on kidney fibrosis, and funding.
###end p 71
###begin title 72
Supplementary Material
###end title 72
###begin title 73
Additional File 1
###end title 73
###begin p 74
###xml 0 191 0 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Higher dose of kinase inhibitors by themselves does not reverse stress fiber actin in mTEC-KO cells; rather, a combination of T&#946;RI inhibitor and a ROCK inhibitor is required to reverse EMT</bold>
###xml 496 500 490 494 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 526 530 520 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 572 578 563 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C-E) </bold>
###xml 605 611 596 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F-G) </bold>
###xml 713 717 704 708 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C) </bold>
###xml 734 738 724 728 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D) </bold>
###xml 759 763 748 752 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E) </bold>
###xml 838 842 825 829 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(F) </bold>
###xml 862 866 848 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G) </bold>
Higher dose of kinase inhibitors by themselves does not reverse stress fiber actin in mTEC-KO cells; rather, a combination of TbetaRI inhibitor and a ROCK inhibitor is required to reverse EMT. mTEC-KO cells were incubated with 100 pM TGF-beta1 for 72 hours, kinase inhibitors were added, and incubation was continued for an additional 24 hours. F-actin was visualized by staining with Texas Red-phalloidin. Cells were viewed with an oil-objective lens at a 630x magnification. mTEC-KO cells were (A) untreated or treated with (B) 100 pM TGF-beta1 for 72 hours followed by (C-E) single kinase inhibitor or (F-G) SB431542 plus a second kinase inhibitor. Single kinase inhibitors and concentrations were as follows: (C) 10 muM SB431542, (D) 10 muM SB203580, and (E) 10 muM Y27632. Combinations of kinase inhibitors were 10 muM SB431542 with (F) 10 muM SB203580 and (G) 10 muM Y27632. White arrows point to stress fibers.
###end p 74
###begin p 75
Click here for file
###end p 75
###begin title 76
Additional File 2
###end title 76
###begin p 77
###xml 0 99 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A combination of T&#946;RI inhibitor and a ROCK inhibitor is required to reverse EMT in mTEC-WT cells</bold>
###xml 334 338 328 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 364 368 358 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 397 401 388 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C) </bold>
A combination of TbetaRI inhibitor and a ROCK inhibitor is required to reverse EMT in mTEC-WT cells. mTEC-WT cells were incubated with 100 pM TGF-beta1 for 72 hours, kinase inhibitors were added, and incubation was continued for an additional 24 hours. F-actin was visualized by staining with Texas Red-phalloidin. mTEC-WT cells were (A) untreated or treated with (B) 100 pM TGF-beta1 followed by (C) 10 muM SB431542 plus 10 muM Y27632. White arrows point to stress fibers.
###end p 77
###begin p 78
Click here for file
###end p 78
###begin title 79
Additional File 3
###end title 79
###begin p 80
###xml 0 65 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946;1 induces ZEB1 and ZEB2 RNA accumulation in mTEC-KO cells</bold>
###xml 344 352 338 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt; 0.05</italic>
TGF-beta1 induces ZEB1 and ZEB2 RNA accumulation in mTEC-KO cells. mTEC-KO cells were incubated for the times indicated with 100 pM TGF-beta1. Cells were harvested and assayed by quantitative RT-PCR for ZEB1 and ZEB2 RNA. Data shown are means + S.E.M.s of two experiments performed in triplicate. Asterisk (*) indicates significant difference (P < 0.05, n = 6).
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Acknowledgements
###end title 82
###begin p 83
We thank Caroline Alexander for NMuMG cells, Bill Sugden for the lentiviral packaging plasmids, Norman Drinkwater for discussions on statistical analysis, Michel Sanders and Xianming Yu for ZEB2 antiserum, and Patricia Keely for comments on the manuscript. We also thank Tawin Iemperdee, Thomas Lentz, Eric Lewellyn, and Natalia M. Solodin for assistance with quantifying immunoblots. This work was supported by CA090875 to FMH, DK064336 to BNB, and AI071928 and CA022443 to JEM. SD was supported in part by T32-CA09135.
###end p 83
###begin article-title 84
Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition
###end article-title 84
###begin article-title 85
Epithelial-mesenchymal transitions in development and pathologies
###end article-title 85
###begin article-title 86
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis
###end article-title 86
###begin article-title 87
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression
###end article-title 87
###begin article-title 88
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation
###end article-title 88
###begin article-title 89
Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment
###end article-title 89
###begin article-title 90
TGFbeta in Cancer
###end article-title 90
###begin article-title 91
Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity
###end article-title 91
###begin article-title 92
Smad-dependent and Smad-independent pathways in TGF-beta family signalling
###end article-title 92
###begin article-title 93
New insights into TGF-beta-Smad signalling
###end article-title 93
###begin article-title 94
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
###end article-title 94
###begin article-title 95
Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition
###end article-title 95
###begin article-title 96
Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta
###end article-title 96
###begin article-title 97
The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer
###end article-title 97
###begin article-title 98
###xml 58 63 <span type="species:ncbi:9606">human</span>
Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights
###end article-title 98
###begin article-title 99
###xml 72 77 <span type="species:ncbi:9606">human</span>
The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression
###end article-title 99
###begin article-title 100
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
###end article-title 100
###begin article-title 101
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
###end article-title 101
###begin article-title 102
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
###end article-title 102
###begin article-title 103
Zeb1 links epithelial-mesenchymal transition and cellular senescence
###end article-title 103
###begin article-title 104
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
###end article-title 104
###begin article-title 105
Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38 MAPK and epithelial plasticity
###end article-title 105
###begin article-title 106
Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis
###end article-title 106
###begin article-title 107
p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration
###end article-title 107
###begin article-title 108
Transforming Growth Factor-beta1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism
###end article-title 108
###begin article-title 109
Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration
###end article-title 109
###begin article-title 110
Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition
###end article-title 110
###begin article-title 111
Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA
###end article-title 111
###begin article-title 112
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
###end article-title 112
###begin article-title 113
Regulation of Par6 by extracellular signals
###end article-title 113
###begin article-title 114
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
###end article-title 114
###begin article-title 115
Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway
###end article-title 115
###begin article-title 116
HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition
###end article-title 116
###begin article-title 117
TGF-beta1 is an autocrine mediator of renal tubular epithelial cell growth and collagen IV production
###end article-title 117
###begin article-title 118
Tubulointerstitial changes as a major determinant in the progression of renal damage
###end article-title 118
###begin article-title 119
Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development
###end article-title 119
###begin article-title 120
Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney
###end article-title 120
###begin article-title 121
Conditional gene targeting in the kidney
###end article-title 121
###begin article-title 122
Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells
###end article-title 122
###begin article-title 123
DeltaEF1 mediates TGF-beta signaling in vascular smooth muscle cell differentiation
###end article-title 123
###begin article-title 124
Matrix metalloproteinases and cellular motility in development and disease
###end article-title 124
###begin article-title 125
Linking TGF-beta-mediated Cdc25A inhibition and cytoskeletal regulation through RhoA/p160(ROCK) signaling
###end article-title 125
###begin article-title 126
TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition
###end article-title 126
###begin article-title 127
###xml 93 98 <span type="species:ncbi:9606">human</span>
A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers
###end article-title 127
###begin article-title 128
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
###end article-title 128
###begin article-title 129
Specificity and mechanism of action of some commonly used protein kinase inhibitors
###end article-title 129
###begin article-title 130
###xml 148 153 <span type="species:ncbi:9606">human</span>
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts
###end article-title 130
###begin article-title 131
Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542
###end article-title 131
###begin article-title 132
Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors
###end article-title 132
###begin article-title 133
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
###end article-title 133
###begin article-title 134
The role of the ZEB family of transcription factors in development and disease
###end article-title 134
###begin article-title 135
Transcriptional regulation of cell polarity in EMT and cancer
###end article-title 135
###begin article-title 136
PAI-1 and functional blockade of SNAI1 in breast cancer cell migration
###end article-title 136
###begin article-title 137
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
###end article-title 137
###begin article-title 138
The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis
###end article-title 138
###begin article-title 139
MicroRNAs as regulators of epithelial-mesenchymal transition
###end article-title 139
###begin article-title 140
The role of microRNAs in metastasis and epithelial-mesenchymal transition
###end article-title 140
###begin article-title 141
Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression
###end article-title 141
###begin article-title 142
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
###end article-title 142
###begin article-title 143
The role of microRNAs in metastasis and epithelial-mesenchymal transition
###end article-title 143
###begin article-title 144
Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
###end article-title 144
###begin article-title 145
The microRNA-200 family regulates epithelial to mesenchymal transition
###end article-title 145
###begin article-title 146
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
###end article-title 146
###begin article-title 147
E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer
###end article-title 147
###begin article-title 148
Cell migration: Rho GTPases lead the way
###end article-title 148
###begin article-title 149
LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta
###end article-title 149
###begin article-title 150
###xml 15 20 <span type="species:ncbi:9606">human</span>
Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation
###end article-title 150
###begin article-title 151
beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition
###end article-title 151
###begin article-title 152
Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis
###end article-title 152
###begin article-title 153
Transforming growth factor-beta receptor inhibition enhances adenoviral infectability of carcinoma cells via up-regulation of Coxsackie and Adenovirus Receptor in conjunction with reversal of epithelial-mesenchymal transition
###end article-title 153
###begin article-title 154
Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest
###end article-title 154
###begin article-title 155
Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinase
###end article-title 155
###begin article-title 156
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors
###end article-title 156
###begin article-title 157
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
###end article-title 157
###begin article-title 158
Development of TGF-beta signalling inhibitors for cancer therapy
###end article-title 158
###begin article-title 159
Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition
###end article-title 159
###begin article-title 160
###xml 181 186 <span type="species:ncbi:9606">human</span>
Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines
###end article-title 160
###begin article-title 161
Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease
###end article-title 161
###begin article-title 162
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies
###end article-title 162
###begin article-title 163
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Phase I clinical trial of a TGF-beta antisense-modified tumor cell vaccine in patients with advanced glioma
###end article-title 163
###begin article-title 164
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
###end article-title 164
###begin article-title 165
Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers
###end article-title 165
###begin article-title 166
The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy
###end article-title 166
###begin article-title 167
Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter
###end article-title 167
###begin article-title 168
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 168

